Sign In
Buy ATXI
$0.300
+0.0300 (+11.11%)
At Close: Jun 22, 2026
Zacks.com featured highlights include: Veritone, Avenue Therapeutics, Turtle Beach, BJ???s Wholesale Club and Atlas Air Worldwide
02:44pm, Tuesday, 26'th May 2020
Zacks.com featured highlights include: Veritone, Avenue Therapeutics, Turtle Beach, BJ???s Wholesale Club and Atlas Air Worldwide
Zacks.com featured highlights include: Avenue Therapeutics, Glu Mobile, Yamana Gold and Z Holdings
02:43pm, Tuesday, 26'th May 2020
Zacks.com featured highlights include: Avenue Therapeutics, Glu Mobile, Yamana Gold and Z Holdings
How Avenue (ATXI) Stock Stands Out in a Strong Industry
12:54pm, Tuesday, 26'th May 2020
Avenue (ATXI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Pick These 5 Stocks With Superb Relative Price Strength
12:42pm, Friday, 22'nd May 2020
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
4 Breakout Stocks for Impressive Returns
10:50am, Friday, 22'nd May 2020
The logic behind the breakout strategy for stock selection is to identify stocks are trading within a narrow band.
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
11:30am, Monday, 11'th May 2020
NEW YORK, May 11, 2020 -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today.
Corcept (CORT) Q1 Earnings Top Estimates, Revenues Rise Y/Y
12:00am, Tuesday, 05'th May 2020
Stocks Analysis by Zacks Investment Research covering: Celgene Corporation, Bristol-Myers Squibb Company, Corcept Therapeutics Incorporated, Avenue Therapeutics Inc. Read Zacks Investment Research's l
Vaxart (VXRT) to Report Q1 Earnings: What's in the Cards?
04:47pm, Wednesday, 29'th Apr 2020
During Vaxart's (VXRT) upcoming Q1 earnings call, investor focus will be on the company's progress with its oral vaccine candidates against SARS CoV-2.
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
03:07pm, Friday, 24'th Apr 2020
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
03:07pm, Friday, 24'th Apr 2020
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
12:30pm, Thursday, 23'rd Apr 2020
The e-poster (816) titled “Intravenous Tramadol is Effective in Management of Postoperative Pain Following Abdominoplasty: A 3-arm Randomized Controlled Trial” presents data from the Phase 3 abdom
5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
11:25am, Thursday, 23'rd Apr 2020
A handful of small-cap stocks have skyrocketed defying the coronavirus-induced market mayhem and extreme volatility.
Avenue Therapeutics (ATXI) Gets a Buy Rating from Oppenheimer
04:32pm, Tuesday, 31'st Mar 2020
In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on Avenue Therapeutics (ATXI), with a price target of $12.00. The
Avenue Therapeutics (ATXI) Gets a Buy Rating from Oppenheimer
04:32pm, Tuesday, 31'st Mar 2020
In a report released today,
Leland Gershell
from Oppenheimer maintained a
Buy
rating on Avenue Therapeutics (
ATXI
–
Research Report
), with a price target of
$12.00
. The company’s shares closed
Analysts' Top Healthcare Picks: Axsome Therapeutics (AXSM), Phasebio Pharmaceuticals (PHAS)
11:29am, Tuesday, 31'st Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Axsome Therapeutics (AXSM), Phasebio Pharmaceuticals (PHAS)
